Company: ACHV
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0000950170-25-069806
Chunk: 6

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
Achieve Life Sciences, Inc.

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share and share amounts) 

     March 31,

     December 31,

     2025

     2024

     ASSETS

     Current assets:

     Cash and cash equivalents [note 5]
      
     $
     13,016

     $
     12,753

     Marketable securities [note 5]

     10,229

     21,607

     Prepaid expenses and other assets

     1,755

     2,107

     Total current assets

     25,000

     36,467

     Other assets and restricted cash [note 5]

     300

     39

     Right-of-use assets [note 8]

     106

     119

     License agreement [note 3 and note 4]

     918

     974

     Goodwill

     1,034

     1,034

     Total assets
      
     $
     27,358

     $
     38,633

     LIABILITIES AND STOCKHOLDERS’ EQUITY

     Current liabilities:

     Accounts payable
      
     $
     1,656

     $
     1,950

     Accrued liabilities other

     1,304

     573

     Accrued clinical liabilities

     1,955

     1,077

     Accrued compensation

     964

     3,027

     Current portion of long-term obligations [note 8]

     57

     55

     Current portion of convertible debt [note 5 and note 6]

     1,194

     —

     Total current liabilities

     7,130

     6,682

     Non-current liabilities

     Non-current portion of convertible debt [note 5 and note 6]

     8,657

     9,837

     Contingent consideration [note 4 and note 5]

     1,240

     1,149

     Long-term obligations [note 8]

     52

     66

     Total liabilities

     17,079

     17,734

     Commitments and contingencies [note 8]

     Stockholders' equity:

     Series A convertible preferred stock, $0.001